Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for CompuMed Inc. (CMPD : OTCBB)
 
 • Company Description   
COMPUMED, INC. is a medical systems company engaged primarily in the application of computer technology to medicine. The main aspects of Co.'s business are (i) the licensing of its proprietary technology in the OsteoGramR, a bone density test that was developed by the Company as a means of aiding physicians in diagnosing and monitoring osteoporosis, (ii) the computer interpretation of electrocardiograms, (iii) TeleCor Services Division, which is engaged in transtelephonic cardiac event monitoring.

Number of Employees: 8

 
 • Price / Volume Information   
Yesterday's Closing Price: $0.15 Daily Weekly Monthly
20 Day Moving Average: 35,177 shares
Shares Outstanding: 42.29 (millions)
Market Capitalization: $6.34 (millions)
Beta: 1.44
52 Week High: $0.39
52 Week Low: $0.14
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -24.05% -14.47%
12 Week -52.96% -48.29%
Year To Date -48.28% -28.37%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
5777 West Century Blvd. Suite 360
-
Los Angeles,CA 90045
USA
ph: 310-258-5000
fax: 310-645-5880
investorrelations@compumedinc.com http://www.compumedinc.com
 
 • General Corporate Information   
Officers
Lee Keddie - Chief Executive Officer; President and Director
David W. Pointer - Chairman of the Board
Laura Carroll - Chief Financial Officer and Corporate Secretary
Loren Den Herder - Director
Charles Gillman - Director

Peer Information
CompuMed Inc. (BJCT)
CompuMed Inc. (CADMQ)
CompuMed Inc. (APNO)
CompuMed Inc. (UPDC)
CompuMed Inc. (IMTIQ)
CompuMed Inc. (CYGN)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: 204914402
SIC: 7374
Fiscal Year
Fiscal Year End: September
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/15/22
Share - Related Items
Shares Outstanding: 42.29
Most Recent Split Date: 10.00 (0.10:1)
Beta: 1.44
Market Capitalization: $6.34 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/15/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: 7.50
PEG Ratio: -
Price Ratios
Price/Book: 1.82
Price/Cash Flow: 4.31
Price / Sales: 1.00
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
Sales Growth
vs. Year Ago Period: -1.90%
vs. Previous Quarter: 3.90%
ROE
03/31/22 - 27.66
12/31/21 - 32.70
09/30/21 - 37.49
ROA
03/31/22 - 17.49
12/31/21 - 20.35
09/30/21 - 23.10
Current Ratio
03/31/22 - -
12/31/21 - -
09/30/21 - 2.70
Quick Ratio
03/31/22 - -
12/31/21 - -
09/30/21 - 2.58
Operating Margin
03/31/22 - 13.58
12/31/21 - 15.16
09/30/21 - 16.87
Net Margin
03/31/22 - 13.60
12/31/21 - 15.18
09/30/21 - 16.87
Pre-Tax Margin
03/31/22 - -
12/31/21 - -
09/30/21 - 16.94
Book Value
03/31/22 - -
12/31/21 - -
09/30/21 - 0.08
Inventory Turnover
03/31/22 - -
12/31/21 - -
09/30/21 - 20.92
Debt-to-Equity
03/31/22 - -
12/31/21 - -
09/30/21 - 0.16
Debt-to-Capital
03/31/22 - -
12/31/21 - -
09/30/21 - 13.80
 

Powered by Zacks Investment Research ©